Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK

The FDA approved Moderna’s RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
The post Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK appeared first on In…